Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Equity (2016 - 2025)

Abeona Therapeutics (ABEO) has 14 years of Return on Equity data on record, last reported at 0.58% in Q3 2025.

  • For Q3 2025, Return on Equity rose 72.0% year-over-year to 0.58%; the TTM value through Sep 2025 reached 0.58%, up 72.0%, while the annual FY2024 figure was 2.32%, 4.0% down from the prior year.
  • Return on Equity reached 0.58% in Q3 2025 per ABEO's latest filing, up from 0.9% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.46% in Q1 2021 and bottomed at 17.06% in Q1 2024.
  • Average Return on Equity over 5 years is 3.01%, with a median of 1.89% recorded in 2023.
  • Peak YoY movement for Return on Equity: crashed -1516bps in 2024, then skyrocketed 1500bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 1.53% in 2021, then crashed by -73bps to 2.64% in 2022, then increased by 2bps to 2.58% in 2023, then rose by 29bps to 1.83% in 2024, then skyrocketed by 68bps to 0.58% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.58% in Q3 2025, 0.9% in Q2 2025, and 2.05% in Q1 2025.